DK342382A - Fremgangsmaade til fremstilling af piperazinoner eller syreadditionssalte deraf og forbindelsernes anvendelse som laegemidler - Google Patents

Fremgangsmaade til fremstilling af piperazinoner eller syreadditionssalte deraf og forbindelsernes anvendelse som laegemidler Download PDF

Info

Publication number
DK342382A
DK342382A DK342382A DK342382A DK342382A DK 342382 A DK342382 A DK 342382A DK 342382 A DK342382 A DK 342382A DK 342382 A DK342382 A DK 342382A DK 342382 A DK342382 A DK 342382A
Authority
DK
Denmark
Prior art keywords
addition salts
piperazinones
medicines
compounds
procedure
Prior art date
Application number
DK342382A
Other languages
English (en)
Other versions
DK154765C (da
DK154765B (da
Inventor
Rudi Beyerle
Heinz Bender
Ursula Schindler
Rolf-Eberhard Nitz
Piero Antonio Martorana
Original Assignee
Cassella Farbwerke Mainkur Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella Farbwerke Mainkur Ag filed Critical Cassella Farbwerke Mainkur Ag
Publication of DK342382A publication Critical patent/DK342382A/da
Publication of DK154765B publication Critical patent/DK154765B/da
Application granted granted Critical
Publication of DK154765C publication Critical patent/DK154765C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/22Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK342382A 1981-08-20 1982-07-30 Analogifremgangsmaade til fremstilling af piperazinoner eller physiologisk acceptable syreadditionssalte deraf DK154765C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3132882 1981-08-20
DE19813132882 DE3132882A1 (de) 1981-08-20 1981-08-20 Neue piperazinone, ihre herstellung und verwendung

Publications (3)

Publication Number Publication Date
DK342382A true DK342382A (da) 1983-02-21
DK154765B DK154765B (da) 1988-12-19
DK154765C DK154765C (da) 1989-05-16

Family

ID=6139695

Family Applications (1)

Application Number Title Priority Date Filing Date
DK342382A DK154765C (da) 1981-08-20 1982-07-30 Analogifremgangsmaade til fremstilling af piperazinoner eller physiologisk acceptable syreadditionssalte deraf

Country Status (23)

Country Link
US (1) US4598079A (da)
EP (1) EP0072932B1 (da)
JP (1) JPS5839673A (da)
KR (1) KR880001622B1 (da)
AT (1) ATE49596T1 (da)
AU (1) AU556064B2 (da)
BG (1) BG40142A3 (da)
CA (1) CA1190227A (da)
DD (1) DD206991A5 (da)
DE (2) DE3132882A1 (da)
DK (1) DK154765C (da)
ES (1) ES8305739A1 (da)
FI (1) FI76325C (da)
GR (1) GR78362B (da)
HU (1) HU190696B (da)
IL (1) IL66566A (da)
NO (1) NO822643L (da)
NZ (1) NZ200761A (da)
PH (1) PH18447A (da)
PL (1) PL139405B1 (da)
PT (1) PT75444B (da)
RO (1) RO85267B (da)
ZA (1) ZA826031B (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772705A (en) * 1985-07-25 1988-09-20 Pennwalt Corporation Processes for the preparation of trans 1,3,4,6,7,11b-hexahydro-7-aryl-2H-pyrazinol[2,1-a]isoquinolines
JPS62198671A (ja) * 1986-02-25 1987-09-02 Toyo Jozo Co Ltd 1−置換アルキル1,2−ジヒドロ−2−ピラジノン誘導体
DE3817198A1 (de) * 1988-05-20 1989-11-30 Cassella Ag Thienyl-piperazinone, ihre herstellung und verwendung
US5238938A (en) * 1989-02-10 1993-08-24 Otsuka Pharmaceutical Co., Ltd. Indole derivatives
DE69029231T2 (de) * 1989-02-10 1997-03-20 Otsuka Pharma Co Ltd Indolderivate, ihre herstellung und diese enthaltendes arzneimittel zum verhindern und behandeln von nephritis
DE3908547A1 (de) * 1989-03-16 1990-09-20 Cassella Ag Thienylessigsaeurederivate, verfahren zu ihrer herstellung, ihre verwendung sowie diese enthaltende arzneimittel und deren herstellung
DE3909379A1 (de) * 1989-03-22 1990-09-27 Cassella Ag Thienylpiperazine, verfahren zu ihrer herstellung, ihre verwendung sowie diese enthaltende arzneimittel und deren herstellung
US5635510A (en) * 1993-05-06 1997-06-03 Merrell Pharmaceuticals Inc. Substituted pyrrolidin-3-yl-alkyl-piperidines
US5883098A (en) * 1993-11-29 1999-03-16 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives, processes for their preparation and pharmaceutical preparations containing them
DE4408530A1 (de) * 1994-03-14 1995-09-28 Hoechst Ag Verfahren zur Herstellung von Aminoethylglycin
AU693936B2 (en) 1994-08-25 1998-07-09 Merrell Pharmaceuticals Inc. Novel substituted piperidines useful for the treatment of allergic diseases
AU697599B2 (en) * 1995-03-15 1998-10-08 Aventis Pharmaceuticals Inc. Heterocyclic substituted piperazinone derivatives as tachykinin receptor antagonists
JP3950170B2 (ja) * 1995-04-13 2007-07-25 アベンティス・ファーマスーティカルズ・インコーポレイテッド タキキニン受容体アンタゴニスト活性を有する新規な置換されたピペラジン誘導体
GB9510600D0 (en) * 1995-05-25 1995-07-19 Fujisawa Pharmaceutical Co Piperazine derivatives
US6211199B1 (en) 1995-11-17 2001-04-03 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
US6423704B2 (en) 1995-12-20 2002-07-23 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
US6194406B1 (en) 1995-12-20 2001-02-27 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
US5932571A (en) * 1996-02-21 1999-08-03 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases
US5922737A (en) * 1996-02-21 1999-07-13 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
US5998439A (en) * 1996-02-21 1999-12-07 Hoescht Marion Roussel, Inc. Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
JP2001518067A (ja) * 1996-04-03 2001-10-09 メルク エンド カンパニー インコーポレーテッド ファルネシルプロテイントランスフェラーゼの阻害剤
SE9603283D0 (sv) * 1996-09-10 1996-09-10 Astra Ab New compounds
TW472045B (en) * 1996-09-25 2002-01-11 Astra Ab Protein kinase C inhibitor compounds, method for their preparation, pharmaceutical composition thereof and intermediate used for their preparation
AR017200A1 (es) 1997-12-23 2001-08-22 Astrazeneca Ab Compuestos inhibidores de la proteina cinasa c, sales farmaceuticamente aceptables de los mismos, formulaciones farmaceuitcas que los comprenden, usode las mismas y proceso para la sintesis de dichos compuestos
SE9800835D0 (sv) 1998-03-13 1998-03-13 Astra Ab New Compounds
US6492406B1 (en) 1999-05-21 2002-12-10 Astrazeneca Ab Pharmaceutically active compounds
US6346625B1 (en) 1999-06-23 2002-02-12 Astrazeneca Ab Protein kinase inhibitors
IN190478B (da) * 2000-11-07 2003-08-02 Sun Pharmaceutical Ind Ltd
US6974869B2 (en) * 2001-09-18 2005-12-13 Bristol-Myers Squibb Pharma Company Piperizinones as modulators of chemokine receptor activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1197089B (de) * 1962-01-25 1965-07-22 Richardson Merrell Inc Verfahren zur Herstellung von 2-Oxo-1, 2, 5, 6-tetrahydropyrazinen
US3390139A (en) * 1964-03-04 1966-03-11 Rohm & Haas Nu-vinyl-2-piperazinones
US3935214A (en) * 1968-07-26 1976-01-27 Donau-Pharmazie Gesellschaft M.B.H. 2-or 3 keto-3-or-2-phenyl-1,4-disubstituted piperazines
DE2438619A1 (de) * 1974-08-12 1976-02-26 Knoll Ag Verfahren zur herstellung von substituierten 2-ketopiperazin-derivaten
AT356122B (de) * 1978-10-17 1980-04-10 Yoshitomi Pharmaceutical Verfahren zur herstellung von neuen pyridazinonderivaten und ihren salzen mit saeuren

Also Published As

Publication number Publication date
RO85267B (ro) 1984-10-30
NZ200761A (en) 1985-04-30
US4598079A (en) 1986-07-01
AU556064B2 (en) 1986-10-23
ES515120A0 (es) 1983-05-01
FI822698L (fi) 1983-02-21
ATE49596T1 (de) 1990-02-15
ZA826031B (en) 1983-07-27
GR78362B (da) 1984-09-26
HU190696B (en) 1986-10-28
ES8305739A1 (es) 1983-05-01
CA1190227A (en) 1985-07-09
KR880001622B1 (ko) 1988-09-02
FI76325C (fi) 1988-10-10
JPS5839673A (ja) 1983-03-08
PT75444B (de) 1985-01-04
DE3280088D1 (de) 1990-02-22
PL237952A1 (en) 1983-03-14
KR840001158A (ko) 1984-03-28
IL66566A (en) 1985-12-31
DE3132882A1 (de) 1983-03-03
RO85267A (ro) 1984-09-29
PL139405B1 (en) 1987-01-31
EP0072932A2 (de) 1983-03-02
EP0072932B1 (de) 1990-01-17
EP0072932A3 (en) 1984-03-21
DD206991A5 (de) 1984-02-15
FI76325B (fi) 1988-06-30
BG40142A3 (en) 1986-10-15
DK154765C (da) 1989-05-16
NO822643L (no) 1983-02-21
DK154765B (da) 1988-12-19
PH18447A (en) 1985-07-08
IL66566A0 (en) 1982-12-31
FI822698A0 (fi) 1982-08-02
PT75444A (de) 1982-09-01
AU8742282A (en) 1983-02-24

Similar Documents

Publication Publication Date Title
DK342382A (da) Fremgangsmaade til fremstilling af piperazinoner eller syreadditionssalte deraf og forbindelsernes anvendelse som laegemidler
ES2075202T3 (es) Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen.
DK173883D0 (da) Substituerede 8-phenylxanthiner
DE3382086D1 (de) Pharmazeutische mixtur.
DK330585D0 (da) Kombinationspraeparat af pyrimido-pyrimidiner og 0-acetylsalicylsyre og deres farmaceutisk acceptable salte
PT75217B (de) Magenvertragliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung
NO864554D0 (no) Flytende oppvaskmiddelblanding for haandvask i kaldt vann.
ATE7139T1 (de) N-aryl-n'-imidazol-2-yl-harnstoffe, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
SE8002831L (sv) Oxitetracyklinberedningar
MX6424A (es) Derivados de tripeptidos, procedimientos para la preparacion de derivados de tripeptidos y composiciones que los contienen.
ES499363A0 (es) Procedimiento para la obtencion de derivados de fenilpipera-cina de 1,3,4-oxadiazolilfenoles
ATE24998T1 (de) Arzneimittel zur behandlung von schlafstoerungen.
DK319384A (da) 1-0-alkyl-3-amino-propan-1,2-diol-2-0-phospholipider, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse
DE3670491D1 (de) Pyrazinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen mit diesen.
ES512995A0 (es) "perfeccionamientos en herrajes de empalme para la union practicable de dos elementos de mobiliario en forma de placa".
ES550285A0 (es) Procedimiento para preparar derivados de acidos aziridin-2- carboxilicos substituidos en n
DE3362130D1 (en) 7-phenyl-7-phenoxymethyl-hexahydro-1,4-oxazepines, their preparation and use
ATE52090T1 (de) Pyrazinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen mit diesen.
ATE42293T1 (de) 3-aminopyrazolo(3,4-d>pyrimidinderivate und deren herstellung.
ATE53846T1 (de) Derivate von dihydroorotsaeure, deren verfahren zur herstellung und deren pharmazeutische zusammensetzungen.
ATE22288T1 (de) Pyrimidin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische zusammenstellungen.
DK201287D0 (da) Bord, isaer til kopimaskiner

Legal Events

Date Code Title Description
PUP Patent expired